Dry eye disease (DED) is one of the most common ocular surface disorders, affecting an estimated 6 million people in Canada ...

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of Systane® PRO Preservative-Free (PF) in Canada as Systane's most advanced formula.

Please provide your email address to receive an email when new articles are posted on . Alcon will buy Lensar’s outstanding shares for $14 per share. The deal is expected to close in the second half ...

Geneva, Switzerland-based Alcon and Orlando, FL-based Lensar have entered a merger agreement through which Alcon intends to acquire Lensar. The acquisition includes the Ally robotic cataract laser ...

LESAGE, W.Va. (WOWK) — A global manufacturer in our region will be getting its hands on a brand new product. The Alcon facility in Cabell County has recently purchased a new warehouse site, where the ...

Alcon innovations featured in more than 75 abstracts across cataract, refractive, visualization and ocular health1 Clinical data presentations and sponsored symposia to highlight the efficacy of Alcon ...

A global company is growing in West Virginia, and it means big investment for the local economy. City and county leaders joined Alcon executives to unveil a $60 million expansion project. The $60 ...

In August, Geneva, Switzerland-based eye care company Alcon agreed to buy Staar Surgical in a deal valued at $1.5 billion, but STAAR has faced opposition to the deal, including from its largest ...

Alcon's Q2 2026 core earnings per share reached USD 0.84, up 10.5 percent from the year-ago quarter and 9.09 percent above ...